Search

everythingexperts & clinicslearnfaqsresearchcommunity

for

Search:↓

This study found that women with post-COVID alopecia showed a diffuse telogen effluvium pattern and distinct trace element imbalances, such as reduced copper and increased selenium levels, helping differentiate this condition from androgenetic alopecia.

Personalized care and evidence-based treatments are crucial for managing skin and hair conditions.

In this case study, a 46-year-old post-transplant woman with poorly controlled diabetes exhibited a rare acquired form of epidermodysplasia verruciformis associated with HPV-49, marked by unique histological findings that distinguishing it from trichodysplasia spinulosa.

This article presents a family case study of dermatopathia pigmentosa reticularis linked to a specific KRT14 gene variant, detailing symptoms and stressing the importance of molecular diagnosis for management.

In this case report, a 54-year-old woman with hirsutism was found to have a benign ovarian cystadenofibroma, which resolved after surgery, highlighting the importance of evaluating postmenopausal women for ovarian causes of androgen excess.

This study explores the controversial condition known as post‐finasteride syndrome, observed in some men who experience lasting sexual, neurological, and psychological side effects after stopping finasteride, emphasizing its rarity and the lack of proven treatments.

The author had undisclosed conflicts of interest related to the original article on post-finasteride syndrome.

In this observational study, researchers found that post-COVID-19 patients with telogen effluvium experienced varying hair loss and quality of life impacts, but no clear link was observed between this hair loss and vitamin D levels or quality of life.

This study observed that patients with post-COVID telogen effluvium had lower serum ferritin levels than controls, but the levels were not indicative of nonanemic iron deficiency.

This study found that women experiencing hair loss post-COVID-19 showed significantly decreased serum copper levels, suggesting potential further research into copper supplementation for preventing and treating post-COVID-19 alopecia.

In this multicenter study, belimumab effectively reduced disease activity in systemic lupus erythematosus patients with joint and skin manifestations, showing significant improvement in acute and subacute skin types earlier than in chronic types, while no significant benefit was observed for nonspecific skin manifestations.

This study found that patients with lupus nephritis experience a greater overall burden than those with systemic lupus erythematosus without nephritis, particularly impacting areas such as family planning, professional life, disease features, medication usage, and quality of life.

In this study, young adult male albino rats treated with finasteride showed a 10% reduction in thickness of the CA1 layer of the hippocampus, suggesting that this atrophy may contribute to memory impairments linked to Post-Finasteride Syndrome.

In this study, postpartum telogen effluvium was often accompanied by other hair loss disorders, highlighting the importance of recognizing these conditions for proper diagnosis and treatment.

This study examined the effects of finasteride on human Leydig cells and found altered methylation in dopaminergic pathways, suggesting potential epigenetic contributions to post-finasteride syndrome, warranting further investigation.

This randomized controlled trial found that vitamin D supplementation significantly improved various post-COVID-19 symptoms, such as fatigue and sleep disturbances, compared to placebo over two months, emphasizing the role of vitamin D deficiency in persistent symptoms among post-COVID-19 patients.

Some men experience persistent sexual, neurological, and psychological symptoms after stopping finasteride, but evidence of permanent damage is inconclusive.

This report describes a complex case of postmenopausal hyperandrogenism with virilization and concurrent rare ovarian tumors, highlighting the critical role of interdisciplinary collaboration in diagnosing and managing such challenging scenarios.

This study at Luigi Sacco University Hospital identified three key macro symptoms of long COVID—neurological, sensorial, and physical—and found that their development is associated with comorbidities, medications during acute COVID-19, and demographic factors like age and gender.

This study, using a descriptive quantitative method, reported that 65.7% of postpartum mothers who received postpartum care were in a healthy condition during the 42-day postpartum period, suggesting the importance of such care in improving maternal health during and beyond this time.

The authors concluded that the concept of postfinasteride syndrome remains contentious and may be more plausibly characterized as a psychiatric condition rather than a consistent medical syndrome.

Treating post-COVID hair loss leads to full recovery, while not treating it often results in ongoing symptoms.

In this study, autologous fat injection was found to be more effective than platelet rich plasma in improving post-burn facial scars, as measured by decreased Vancouver scores and increased epidermal thickness among 60 patients.

This study compared the effectiveness of topical finasteride, oral finasteride, and topical minoxidil over 12 months in postmenopausal women with androgenetic alopecia, exploring their therapeutic effects on this population. Results are not reported in the abstract.

Using a gel head pad during surgery can cause hair loss in children.

Among adults suffering from post-COVID syndrome, this study reported fatigue as the most common long-term effect, observed in 71.4% of cases, followed by shortness of breath, anxiety/depression, and memory and attention deficits.

This study proposes that combining trazodone and clomiphene citrate could potentially restore libido synaptic circuits and treat post-finasteride syndrome, which involves persistent sexual dysfunction after discontinuing finasteride treatment.

In this review, the authors discuss various treatments and therapies available to address hair loss following COVID-19 infection, highlighting that professional diagnosis and therapy are crucial to restoring normal hair growth and scalp health in affected individuals.

In this study, researchers found that 11.5% of older outpatients in Vietnam experienced post-COVID-19 hair loss; women, those single or divorced, and individuals with prior COVID-19 hospitalizations were more likely to report hair loss.

The researchers proposed that an epigenetic change in brain androgen receptors caused by finasteride could lead to post finasteride syndrome, while trazodone might reverse this effect by altering the epigenetic expression related to erection and libido.